BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2181 related articles for article (PubMed ID: 21404654)

  • 21. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    Respirology; 2009 Mar; 14(2):276-81. PubMed ID: 19210655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.
    Chung WK; Zheng ZL; Sung JY; Kim S; Lee HH; Choi SJ; Yang J
    Clin Microbiol Infect; 2010 Jul; 16(7):960-5. PubMed ID: 19906274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
    Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
    Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
    Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
    Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
    Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection.
    Maeda T; Banno S; Maeda S; Naniwa T; Hayami Y; Watanabe M; Itoh R; Sato S; Ueda R
    Mod Rheumatol; 2010 Feb; 20(1):18-23. PubMed ID: 19779763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals.
    Jones S; de Gijsel D; Wallach FR; Gurtman AC; Shi Q; Sacks H
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1190-5. PubMed ID: 17958980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India.
    Dogra S; Narang P; Mendiratta DK; Chaturvedi P; Reingold AL; Colford JM; Riley LW; Pai M
    J Infect; 2007 Mar; 54(3):267-76. PubMed ID: 16733068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O; Kumar D
    Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
    Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
    Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of usefulness of a whole blood interferon gamma assay (QuantiFERON TB-2G) for diagnosing active tuberculosis in immunocompromised patients].
    Ito I; Tada K; Ootera H; Sakurai T; Iwasaki H
    Kekkaku; 2011 Feb; 86(2):45-50. PubMed ID: 21404649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
    Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
    Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
    Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
    J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 110.